Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

[1]  S. Duffy,et al.  Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. , 2013, European journal of cancer.

[2]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Wenz,et al.  Relative Biologic Effectiveness (RBE) of 50 kV X-rays measured in a phantom for intraoperative tumor-bed irradiation. , 2013, International journal of radiation oncology, biology, physics.

[4]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.

[5]  M. Togni,et al.  Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial , 2013, The Lancet.

[6]  Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A , 2013, Radiation oncology.

[7]  F. Wenz,et al.  Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A , 2012, Breast Cancer Research and Treatment.

[8]  M. Bulsara,et al.  482 Patient Preferences for Adjuvant Radiotherapy in Early Breast Cancer – an Australian Sub-study of the International TARGIT Trial , 2012 .

[9]  M. Baum,et al.  Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. , 2011, International journal of radiation oncology, biology, physics.

[10]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[11]  D. Joseph,et al.  Significantly Better Cosmetic Outcome After Intraoperative Radiotherapy Compared With External Beam Radiotherapy for Early Breast Cancer: Objective Assessment of Patients From a Randomized Controlled Trial , 2011 .

[12]  L. Esserman,et al.  Cost-effectiveness of intraoperative radiation therapy for breast conservation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Lawton.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009) , 2011 .

[14]  F. Wenz,et al.  Radiobiological Comparison of Hypofractionated Accelerated Partial-Breast Irradiation (APBI) and Single-Dose Intraoperative Radiotherapy (IORT) with 50-kV X-Rays , 2010, Strahlentherapie und Onkologie.

[15]  L. Esserman,et al.  Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial , 2010, The Lancet.

[16]  D. Joseph,et al.  Better Cosmetic Outcome After Intraoperative Radiotherapy Compared With External Beam Radiotherapy for Early Breast Cancer: Objective Assessment of Patients From a Randomized Controlled Trial , 2010 .

[17]  Catherine C. Park,et al.  234 Patient preference for choosing intra-operative or external-beam radiotherapy following breast conservation , 2010 .

[18]  R. Pötter,et al.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  T. Julian,et al.  Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, International journal of radiation oncology, biology, physics.

[20]  J. Vaidya,et al.  Beneficial effects of intraoperative radiotherapy on tumor microenvironment could improve outcomes (Int J Radiat Oncol Biol Phys 2008;72:1575-1581). , 2009, International journal of radiation oncology, biology, physics.

[21]  John P Klein,et al.  Methods for equivalence and noninferiority testing. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  J. Overgaard,et al.  Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  F. Wenz,et al.  Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays. , 2008, International journal of radiation oncology, biology, physics.

[24]  F. Lovat,et al.  Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical Wounding , 2008, Clinical Cancer Research.

[25]  J. Vaidya.  Partial breast irradiation using targeted intraoperative radiotherapy (Targit) , 2007, Nature Clinical Practice Oncology.

[26]  M. Chaplain,et al.  A mathematical model of breast cancer development, local treatment and recurrence. , 2007, Journal of theoretical biology.

[27]  Haesook T. Kim.  Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis , 2007, Clinical Cancer Research.

[28]  R. Pötter,et al.  Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. , 2005, International journal of radiation oncology, biology, physics.

[29]  F. Wenz,et al.  Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery. , 2006, International journal of radiation oncology, biology, physics.

[30]  L. Laster,et al.  Non‐inferiority trials: the ‘at least as good as’ criterion with dichotomous data , 2006, Statistics in medicine.

[31]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[32]  F. Wenz,et al.  Radiobiological Aspects of Intraoperative Radiotherapy (IORT) with Isotropic Low-Energy X Rays for Early-Stage Breast Cancer , 2005, Radiation research.

[33]  Melania Pintilie,et al.  Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[34]  Barbara L. Smith,et al.  Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.

[35]  M Baum,et al.  Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. , 2004, The British journal of radiology.

[36]  M. Baum,et al.  Intraoperative radiotherapy for breast cancer. , 2004, The Lancet. Oncology.

[37]  A. Luini,et al.  Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. , 2003, Archives of surgery.

[38]  Norman Wolmark,et al.  Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Michael Baum,et al.  The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[40]  Douglas G Altman,et al.  Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls , 2002, The Lancet.

[41]  J. Vaidya.  A novel approach for local treatment of early breast cancer. , 2002 .

[42]  M Metaxas,et al.  Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  G Noël,et al.  [Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[44]  J. Vermorken.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.

[45]  W. F. Athas,et al.  Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. , 2000, Journal of the National Cancer Institute.

[46]  Mike Clarke,et al.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .

[47]  M. Chaplain,et al.  Does breast cancer exist in a state of chaos? , 1999, European journal of cancer.

[48]  V. Sacchini.  Multicentricity and recurrence of breast cancer , 1996, The Lancet.

[49]  Jayant S. Vaidya,et al.  Multicentricity of breast cancer: whole-organ analysis and clinical implications. , 1996, British Journal of Cancer.

[50]  M Baum,et al.  Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[51]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.